Catalio Capital Management, LPFirm match from fund name (lower confidence)
Catalio Genesis Fund X, LLC
Open, writing first checks
Open: first sale Feb 2026, per Form D (fund age approximates vintage)
- Vintage
- 2026
- Fund size
- $19.1M (Form D)
- Stages
- Not stated
- Sectors
- Biotech, Medical devices, Healthtech, Digital health, Life sciences and research tools
- Regions
- Not stated
01 · Thesis
Invests in innovative healthcare companies at all stages, from inception to IPO, focusing on drugs, devices, diagnostics and data. Often backs companies founded by world-renowned serial scientist-entrepreneurs with strong IP.Inferred from the firm's website
02 · Initial check
$191K to $318K (estimated from fund size)
Estimated from Form D
03 · Who to approach
Named on this fund's Form D
- George C. Petrocheilos, Co-Founder & Managing Partner
- R. Jacob Vogelstein, Ph.D., Co-Founder & Managing Partner
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideCatalio invests in innovative healthcare companies at all stages and sizes, across the capital structure.
At Catalio, we invest in innovative healthcare companies at all stages and sizes, and throughout the capital structure.
https://cataliocapital.com/
06 · Sources
Last verified: Oct 28, 2026